An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...

By Michael Erman Feb 5 (Reuters) - Bristol Myers Squibb on Thursday forecast 2026 revenue and profit above Wall Street ...

It's still unclear if all patients, particularly those with insurance coverage, will see more cost savings from using that ...

President Trump launched TrumpRx.gov, connecting Americans directly to pharmaceutical giants for massive "Most Favored Nation ...